Chemical Determination of Abacavir Sulfate, Abarelix, and Abiraterone Acetate

Wiki Article

These agents, Abacavir Sulfate, Abarelix, and Abiraterone Acetate, each possess distinct chemical organizations leading to their varying pharmacological effects. Abacavir Sulfate, a nucleoside reverse transcriptase inhibitor, is readily recognized via its molecular formula – C₁₄H₁₅N₆O₄·H₂SO₄ – and characteristic spectral properties observed in techniques such as mass spectrometry and infrared spectroscopy. Abarelix, a gonadotropin-releasing hormone (GnRH) receptor inhibitor, presents with a complex peptide sequence, typically requiring amino acid sequencing and peptide mapping for full identification. Finally, Abiraterone Acetate, a CYP17 inhibitor utilized in prostate cancer treatment, can be verified through its precise mass and fragmentation patterns acquired through gas chromatography-mass spectrometry (GC-MS) alongside nuclear magnetic resonance ALTAZANAVIR SULFATE 229975-97-7 (NMR) analytical data, ensuring its correct chemical characterization.

Product: Abacavir Sulfate Sulfate (CAS 188062-50-2) & Connected Compounds

Explore the extensive listing detailing Abacavir Disulfate Sulfate, identified by CAS number 188062-50-2, and a variety of related substances. The offering includes multiple qualities to satisfy particular research and creation requirements. Discover detailed information including analytical results and available packaging options. Additionally, review our lineup of structurally akin substances that might be beneficial in your current project. This listing is intended to assist streamlined acquiring of pure pharmaceutical reagents.

Chemical Reference: Abarelix and Abirateron Acetate CAS Identifiers

For chemists and drug professionals needing precise pharmaceutical identification, correct CAS identifiers are crucial. Specifically, abarelix, a GnRH-releasing hormone agonist used in treating prostate disease, is assigned the Registry code 65572-21-8. Furthermore, abiraterone acetate, a powerful drug in advanced tumors, carries the Registry identifier 389292-17-3. Careful recording and confirmation of these Registry numbers are imperative to ensure proper compound recognition and subsequent operations. This identifiers are widely accessible through multiple scientific databases. Regularly consult official sources for the latest information.

Drug Ingredients: Abacavir , , Abiraterone , Registry Listings

The determination of key pharmaceutical components often relies on accurate chemical references. Specifically, this section briefly examines three notable instances: Abacavir Sodium, a pyrimidine reverse enzyme inhibitor; , a GnRH antagonist; and Abiraterone, utilized in malignant management. These substance is associated with a unique Chemical Abstracts Service number, supplying a universal method for identifying data and verifying accurate communication within the research field. Refer the respective resources for full listings and related information.

Chemical Abstracts Service Number Database: Entries for Abacavir Sulfate, Abarelix, Abiraterone Acetate

The vast Chemical Abstracts Service (CAS) number is an critical resource for researchers and industry professionals alike. This article succinctly details records pertaining to three significant therapeutic compounds: Abacavir Sulfate, a medication used to combat HIV; Abarelix, a antagonist used in therapy; and Abiraterone Acetate Salt, a powerful drug applied in the management of metastatic advanced cancer. Accessing the accurate CAS identification for each molecule allows for unambiguous identification and promotes precise research retrieval. These unique identifiers are necessary for scientific validation and uniform reporting across the industry.

Leveraging Application Programming Interface Substance Data: Item Determination with CAS Numbers

Accurate item identification is critical in the substance industry, and Web API substance data provides a consistent answer. Particularly, Chemical Abstracts Service numbers act as individual labels for material entities, enabling effortless consolidation with collections and platforms. Such methodology furthermore enhances information quality but likewise accelerates processes related to analysis, purchase, and compliance documentation. Moreover, accessing this data via an Application Programming Interface promotes automation and reduces the chance for operator error.

Report this wiki page